Fulcrum Therapeutics to Participate in Upcoming May Conferences


CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following conferences:

Go here to see the original:
Fulcrum Therapeutics to Participate in Upcoming May Conferences

Related Posts